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Abstract
Background: Complications from diabetes mellitus can compromise a driver’s ability to safely operate a motor vehicle, yet
little is known about whether euglycemia predicts normal driving risks among adults with diabetes. We studied the
association between glycosylated hemoglobin (HbA1c) and the risk of a motor vehicle crash using a population-based case
control analysis.
Methods and Findings: We identified consecutive drivers reported to vehicle licensing authorities between January 1, 2005
to January 1, 2007 who had a diagnosis of diabetes mellitus and a HbA1c documented. The risk of a crash was calculated
taking into account potential confounders including blood glucose monitoring, complications, and treatments. A total of 57
patients were involved in a crash and 738 were not involved in a crash. The mean HbA1c was lower for those in a crash than
controls (7.4% versus 7.9%, unpaired t-test, p=0.019), equal to a 26% increase in the relative risk of a crash for each 1%
reduction in HbA1c (odds ratio=1.26, 95% confidence interval 1.03–1.54). The trend was evident across the range of HbA1c
values and persisted after adjustment for measured confounders (odds ratio=1.25, 95% confidence interval 1.02–1.55). The
two other significant risk factors for a crash were a history of severe hypoglycemia requiring outside assistance (odds
ratio=4.07, 95% confidence interval 2.35–7.04) and later age at diabetes diagnosis (odds ratio per decade=1.29, 95%
confidence interval 1.07–1.57).
Conclusions: In this selected population, tighter glycemic control, as measured by the HbA1c, is associated with an
increased risk of a motor vehicle crash.
Citation: Redelmeier DA, Kenshole AB, Ray JG (2009) Motor Vehicle Crashes in Diabetic Patients with Tight Glycemic Control: A Population-based Case Control
Analysis. PLoS Med 6(12): e1000192. doi:10.1371/journal.pmed.1000192
Academic Editor: Leif Groop, Lund University Hospital, Sweden
Received April 21, 2009; Accepted October 23, 2009; Published December 8, 2009
Copyright:  2009 Redelmeier et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This project was supported by the Canada Research Chair in Medical Decision Sciences. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Abbreviations: HbA1c, glycosylated hemoglobin
* E-mail: dar@ices.on.ca
PLoS Medicine | www.plosmedicine.org 1 December 2009 | Volume 6 | Issue 12 | e1000192Introduction
Diabetic patients account for substantial amounts of driving.
At a population disease prevalence of 5% to 7% for this
diagnosis, general mobility statistics would suggest that diabetic
patients drive about 250 million miles during the average day in
the United States [1,2]. Such distances are extraordinary—
greater than traveling from the earth to the sun and back [3].
The exact figure could be eithers o m e w h a tl a r g e ri fd i a b e t e s
correlates with a sedentary lifestyle that favors driving or
somewhat smaller if diabetes is associated with incapacitating
complications that leave the patient institutionalized [4]. The
substantial driving distances are likely to continue into the
future given societal reliance on road travel for work, recreation,
leisure, and health care [5].
On average, a population with a large amount of driving tends
to have a large number of crashes. If diabetic drivers were identical
to average American adults, the baseline risk of a serious crash
would be about one in 20 per year [6]. This number would
amount to about five diabetic drivers killed and another 50
incapacitated each day from motor vehicle crashes in the United
States. Even for individuals who crash without injuries, the event
can disrupt the ideals of regular exercise, a prudent diet, work
productivity, and other elements of lifestyle [7]. Impairments from
retinopathy, neuropathy, and hypoglycemia might make the
average diabetic driver more prone to crashing than the prevailing
population average [8].
Governmental policies sometimes restrict the licenses of
diabetic drivers on grounds that the disease makes the individual
unfit to drive [9]. Different states in the US have different
regulations, yet even permissive regions require drivers who hold
commercial licenses to document glycemic control [10–15]. The
laws are based on the theory that glycemic control predicts lower
driving risk either by preventing retinopathy and other compli-
cations or by indirectly distinguishing persons who are innately
conscientious [16,17]. Guidelines in Canada state, for example,
‘‘In general, a patient is considered fit to drive if it can be
demonstrated that he or she is fastidious and knowledgeable
about controlling his or her blood glucose levels …’’ [18]. In this
study we tested whether glycemic control, as measured by
glycosylated hemoglobin (HbA1c), was associated with the risk of
a motor vehicle crash.
Methods
Patient Selection
We selected all drivers reported to the Ontario Ministry of
Transportation Medical Advisory Board who had an underlying
diagnosis of diabetes mellitus. This population-based sampling
strategy included all licensed drivers in Ontario with the accrual
interval spanning from January 1, 2005 to January 1, 2007,
representing all years available for analysis. Candidates were
identified from mandatory annual reviews submitted by drivers
who held commercial licenses or mandatory reports submitted in
the aftermath of a documented motor vehicle crash. We also
included all other diabetic patients reviewed for any other reason
such as those appealing a license suspension or those with
notifiable medical conditions reported by physicians [19].
Individuals were excluded if no HbA1c was available; otherwise,
all drivers were analyzed. This study was approved by the
Research Ethics Board of Sunnybrook Health Sciences Center
and conducted using privacy safeguards at the Institute for Clinical
Evaluative Sciences.
Crash Outcome
We classified each individual according to the manner
through which they came to the attention of the licensing
authority. Individuals involved in a motor vehicle crash were
defined as cases. Such cases were identified by the authorities
responsible for investigating a crash. All other individuals who
were not involved in a motor vehicle crash were defined as
controls. Such controls are not a random sample of the pop-
ulation because they come to attention by reports submitted
by others or because of legal requirements for having a valid
driver’s license. Controls ought to include all diabetic drivers
who developed diabetes or obtained a license during the study
period, but do not because of noncompliance with legislation or
other reasons.
Glycemic Control
We obtained the medical record of each person’s diabetes care
from available files. These records reflect submissions from
community physicians corresponding to each patient; the accuracy
of these reports has never been validated although each is
submitted and signed by a licensed physician [20]. We used the
hemoglobin HbA1c as the primary measure of long term blood
glucose control since it reflects glycemic control over 2 to 3 mo, is
widely available with a liquid chromatography assay, and is the
objective standard for traffic policy decisions around the world
[21,22]. In secondary analyses we also examined the patients’
degree of monitoring, total years since diagnosis of diabetes, and
specific complications. These secondary analyses were conducted
for exploratory purposes and did not involve statistical power
calculations in advance.
Missing Data
Missing data were handled using methods blind to outcome
status. The type of diabetes was not always recorded in available
documents; instead, we classified individuals on the basis of
whether they had started insulin treatment before or after age
20 y. The duration of diabetes was also gauged by categorizing
patients who had been on insulin for 20 y or more. Data on
specific complications, monitoring, and treatments were accepted
as recorded under the assumption that not documented implied
not present. Information on diet, exercise, weight, compliance,
alcohol, lifestyle, age of first licensing, driving patterns, commercial
licenses, past infractions, diabetic education, visual acuity, and at-
fault analysis was not recorded and deemed not possible to impute
from sources.
Statistical Analysis
Our primary analysis compared the mean HbA1c among cases
involved in a crash to controls who were not involved in a crash
using an unpaired t-test with two-tailed statistics. Logistic
regression was used to quantify associations using odds ratios
and adjusting for baseline confounders using a step-wise forward
selection procedure (models constrained to 12 events per covariate
to avoid overfitting and used the c-statistic to gauge overall
accuracy) [23]. Odds ratios are good approximations of relative
risk for low probability events (such as the annual risk of a crash)
[24]. A nonparametric test for trend was also conducted using the
Cochran-Armitage method [25]. Data validation was conducted
blind to outcome to correct HbA1c values outside the plausible
range (4.0%–16.0%) for magnitude anomalies (e.g., 6.5% reported
as 0.65 or 0.065). The sample size was estimated to provide 80%
power to detect a 0.5% difference in HbA1c between the two
groups of patients.
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During the 2-y study interval a total of 3,900 individuals were
reported to licensing authorities, of whom 795 were diabetic
patients who had HbA1c values documented. Their mean age was
52 y, 84% were men, and the average patient had about a 20-y
history of diabetes (Table 1). Most patients had end organ damage
including retinopathy, nephropathy, and neuropathy. About 81%
were treated with insulin, 27% with oral glucose-lowering
medications, and 15% with neither insulin nor an oral medication.
Overall, one in six lacked hypoglycemic awareness and one-third
had a history of hypoglycemia that required outside assistance.
The spread of HbA1c values was remarkable, ranging from 4.4%
to 14.7%.
Overall, 57 patients were involved in a crash (cases) and 738
were not involved in a crash (controls). In keeping with a potential
adverse association, the mean HbA1c was lower among those who
crashed than controls (7.4% versus 7.9%, p=0.019). This
association was equivalent to a 26% increase in the risk of a
crash for each 1% reduction in HbA1c (odds ratio=1.26, 95%
confidence interval 1.03–1.54). The finding was evident across the
range of HbA1c values and suggested that the risk of a crash in the
bottom quartile was more than twice the risk in the top quartile
(Figure 1). The absolute difference amounted to a net increase of
29 total crashes (95% confidence interval 16–46) had the risk in
the highest quartile extended to all other quartiles.
The observed association between low HbA1c values and
increased crash risks tended to be consistent for patients with
different characteristics (Figure 2). The risk was observed for
patients with longer and shorter durations of diabetes, regardless of
whether measured as time since diagnosis or time since starting
insulin. Moreover, the risk was observed for those treated with
insulin, oral hypoglycemics, both, or neither. In addition, the risk
extended to those with no mention of severe hypoglycemia,
hypoglycemic unawareness, or other specific chronic complica-
tions. The largest single anomaly (yet not statistically significant
and overlapping the main analysis) was the subgroup not treated
with insulin or oral hypoglycemic medications.
The observed association between low HbA1c values and
increased crash risks persisted when adjusted for potential
confounders. Analyses adjusting for age yielded approximately
the same increase in the relative risk of a crash for each 1%
reduction in HbA1c (odds ratio=1.27, 95% confidence interval
1.04–1.55). Similarly, analyses adjusting for age, age at diagnosis,
and age when insulin started also yielded a comparable increase in
the risk of a crash (odds ratio=1.26, 95% confidence interval
1.00–1.58). Analyses adjusting for both age, gender, and each
separate complication also yielded about a 25% increase in the risk
Table 1. Patient characteristics.
Characteristic Feature Crash (n=57) Control (n=738)
Age Mean years 50 (15) 52 (14)
Sex Female 13 (23) 111 (15)
Male 44 (77) 627 (85)
Age at diagnosis Mean years 26 (16) 32 (16)
Age insulin started Mean years 29 (19) 34 (18)
Extent Insulin started,age 20 y 19 (40) 157 (26)
Duration of insulin treatment $20 y 21 (43) 210 (35)
Comorbidities Hypertension 42 (74) 453 (61)
Retinopathy 44 (77) 604 (82)
Nephropathy 40 (70) 590 (80)
Neuropathy 46 (81) 632 (86)
Stroke 4 (7) 33 (4)
Coronary artery disease
a 5 (9) 61 (8)
Hypoglycemia Symptom awareness of hypoglycemia
b 49 (86) 607 (82)
Severe hypoglycemia in past 2 y
c 34 (60) 200 (27)
Glucose monitoring Computerized logs 13 (23) 90 (12)
Handwritten logs 43 (75) 478 (65)
Checks at least twice daily 48 (84) 576 (78)
Treatment Insulin 47 (82) 593 (80)
Oral hypoglycemic 21 (37) 197 (27)
Both 20 (35) 165 (22)
Neither 9 (15) 113 (15)
Additional other medications ($1) 33 (58) 481 (65)
Three or more other medications ($3) 13 (23) 187 (25)
Data are count (percentage) except where noted as mean (standard deviation).
aIncludes myocardial infarction.
bIncludes sweating or any other signal symptom.
cDefined as requiring outside assistance.
doi:10.1371/journal.pmed.1000192.t001
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1.30). None of the statistical models yielded a contrary result
although results in some models were not statistically significant.
Two other patient characteristics were independent risk factors for a
crash. A history of severe hypoglycemia that required outside help was
associated with about a 4-fold increase in risk (odds ratio=4.07, 95%
confidence interval 2.35–7.04). In addition, older age of diabetes
diagnosis (expressed as increase per decade) was also associated with an
increase in risk (odds ratio=1.29, 95% confidence interval 1.07–1.57).
No other baseline characteristic (Table 1) was a significant predictor of
risk in univariate analyses. Multivariate analysis that included both
severe hypoglycemia requiring outside help and age at diabetes
diagnosis had a mid-range overall accuracy (c-statistic=0.65) and
showed a persistent association of HbA1c with crash risk (odds
ratio=1.25, 95% confidence interval 1.02–1.55).
Discussion
Westudied a selected sample of diabetic adults driving during a 2-y
interval using a population-based approach. The main finding was
that lower HbA1c levels were associated with an increased risk of a
motor vehicle crash. The adverse association was observed across the
range of HbA1c values, persisted after adjustment for independent
confounders, yet was not as large as the relative risk associated with a
history of severe hypoglycemia requiring outside assistance. The
attributable risk was substantial, so that eliminating the association by
extrapolating the risk observed at the highest HbA1c quartile to all
drivers at all HbA1c quartiles would have eliminated about half of all
observed crashes. These findings are difficult to explain with random
chance, reverse-causality, or simple reporting bias.
A major limitation of our research relates to the nonrandomized
design and sample selection. That is, adults with diabetes self-select
how to control their glucose as well as how to drive a vehicle. One
explanation for the association, therefore, could be that those who
are stringent about controlling their blood glucose are paradox-
ically more careless about driving a vehicle. Another explanation
could be that tightly controlled patients drive in more dangerous
settings. A third explanation could be that unreported alcohol
consumption influences both driving risk and glucose control (e.g.,
impaired liver glucogenesis). Many other biases are possible
including Berkson’s paradox, Neyman Bias, Hawthorn effects,
restricted generalizability, imperfect compliance with the law, and
spectrum bias [19,26]. These limitations are unavoidable in
trauma research except for studies that focus on volunteer samples,
unnatural tasks, or hypothetical risks [27].
We have no data on baseline time spent driving, yet such data are
unlikely to explain our findings. First, all individuals maintained valid
licenses, remained active in the community, and were at risk for a
crash. Second, no prior study shows diabetic adults drive substantially
more than the prevailing average (or that small differences in HbA1c
predictlarge differences in driving time) [28]. Third, researchin other
domains indicates time spent driving is a poor predictor of crash risk;
for example, teenagers account for a large number of crashes despite
a small amount of time spent driving and senior citizens have a
heightened risk primarily explained by the very low distance drivers
[29,30]. No surprise, therefore, that license regulations account for
fitness to drive but have no restrictions based on the amount of
driving the person intends.
Our findings join a growing and contentious literature
correlating low HbA1c values with adverse consequences in adults
with diabetes mellitus. For example, three recent randomized trials
found that intensive treatment regimens led to both lower HbA1c
values and an increased incidence of severe hypoglycemia among
diabetic patients [31–33]. These trials and our study do not prove
that striving for a normal HbA1c is harmful; instead, the adverse
association might indicate that customary treatments for achieving
euglycemia are inexact and potentially hazardous to high level
cognitive behavior [34–37]. Many patients, furthermore, are
aware of their HbA1c results so that a double-blinded trial
becomes unfeasible and susceptible to subtle confounders. Such
behavioral factors are germane in clinical research since patients
with a normalized HbA1c might develop a false sense of security
whereas those with a high HbA1c might abandon their activities
and ironically become protected from mobility related injury [38].
The basic implication of our study is to underscore the difficulty
in judging fitness-to-drive in adults with severe diabetes mellitus
[39]. This pitfall calls into question traffic laws that prevail in the
United States, United Kingdom, Canada, Germany, Holland,
Australia, and other countries that single out diabetic patients for
specialized review. At a minimum, the data suggest that a patient’s
HbA1c level is neither necessary nor sufficient for determining
fitness-to-drive. Whether a comprehensive medical review,
functional performance assessment, formal driving test, detailed
record of hypoglycemia episodes, or other measure could be more
accurate and cost-effective remains a topic for future research.
Unfortunately, most other measures of diabetes control are based
on self-report that can be easily denied when applying for a driving
license.
Acknowledgments
The views expressed in this paper are those of the authors and do not
necessarily reflect those of the Ontario Ministry of Health or the Ontario
Ministry of Transportation. We thank the following individuals for helpful
comments on earlier drafts of this article: Gillian Booth, Daniel Hackam,
Michael Schull, Baiju Shah, and Steven Shumak.
Figure 1. Glycemic control and risk of a motor vehicle crash.
Relative risk of a motor vehicle crash for drivers at different levels of
glycemic control. x-Axis shows glycemic control as measured by
glycosylated hemoglobin concentration and grouped into approximate
quartiles. Data in square brackets show individuals in each group as
[numberofcases/numberofcontrols].y-Axisshowsrelativerisk ofa crash
expressed in odds-ratio calibrated using the top glycemic quartile as
referent. Solid circles indicate point-estimates and vertical lines indicate
standard error bars. p-Value tests for trend across all four quartiles.
Overall results show a correlation between lower HbA1c levels and
higherrelativerisk ofacrashwithnoevidenceofaU-shapedrelationship.
doi:10.1371/journal.pmed.1000192.g001
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expressed as odds ratio (solid circle) and 95% confidence interval (horizontal line) per 1% point decrease in HbA1c. Analyses of chronic complication
subgroups exclude patients reporting corresponding symptom. Results for full cohort appear at bottom and show an odds ratio of 1.26 with 95%
confidence interval 1.03–1.54.
doi:10.1371/journal.pmed.1000192.g002
Vehicle Crashes in Diabetic Patients
PLoS Medicine | www.plosmedicine.org 5 December 2009 | Volume 6 | Issue 12 | e1000192Author Contributions
ICMJE criteria for authorship read and met: DAR ABK JGR. Agree with
the manuscript’s results and conclusions: DAR ABK JGR. Designed the
experiments/the study: DAR JGR. Analyzed the data: DAR. Collected
data/did experiments for the study: DAR ABK. Wrote the first draft of the
paper: DAR. Contributed to the writing of the paper: DAR ABK JGR.
References
1. Fatality analysis reporting system encyclopedia. Washington (D.C.): National
Highway Traffic Safety Administration, Available: http://www-fars.nhtsa.dot.
gov/Main/index.aspx. Accessed 15 October 2009.
2. Centers for Disease Control and Prevention (2005) National diabetes fact sheet:
general information and national estimates on diabetes in the United States,
2005. Atlanta: U.S. Department of Health and Human Services, Centers for
Disease Control and Prevention. Available: http://www.diabetes.org/
uedocuments/NationalDiabetesFactSheetRev.pdf. Accessed 15 October 2009.
3. Wikipedia, the Free Encyclopedia. Astronomical unit. Available: http://en.
wikipedia.org/wiki/Astronomical_unit. Accessed 15 October 2009.
4. Evans L (2004) Traffic safety. Bloomfield Hills (Michigan): Science Serving
Society. 444 p.
5. Steg L, Vlek C, Slotegraaf G (2001) Instrumental-reasoned and symbolic-
affective motives for using a motor car. Transportation Research Part F:
Psychology and Behaviour 4: 151–169.
6. Redelmeier DA, Weinstein MC (1999) Cost-effectiveness of regulations against
using a cellular telephone while driving. Med Decis Making 19: 1–8.
7. Winston FK, Kassam-Adams N, Vivarelli-O’Neill C, Ford J, Newman E, et al.
(2002) Acute stress disorder symptoms in children and their parents after
pediatric traffic injury. Pediatrics 109: e90.
8. Marshall SC (2008) The role of reduced fitness to drive due to medical impairments
in explaining crashes involving older drivers. Traffic Inj Prev 9: 291–298.
9. Langford J, Braitman K, Charlton J, Eberhard J, O’Neill D, et al. (2008)
Licensing authorities’ options for managing older driver safety—practical advice
from the researchers. Traffic Inj Prev 9: 278–281.
10. Distiller LA, Kramer BD (1996) Driving and diabetics on insulin therapy. S Afr
Med J 86: 1018–1020.
11. Flanagan DE, Watson J, Everett J, Cavan D, Kerr D (2000) Driving and insulin–
consensus, conflict or confusion? Diabet Med 17: 316–320.
12. Cundy T, Drury P (2000) Vocational driving, diabetes and insulin use. N Z Med J
113: 317–318.
13. Polak BC, van Rijn LJ, Korver C (2003) Fitness to drive in people with diabetes
mellitus; a recommendation from the Health Council of the Netherlands. Ned
Tijdschr Geneeskd 147: 1243.
14. Marcinkiewicz A, Szosland D (2007) Medical certification for diabetic drivers in
the selected European Union member states. Med Pr 58: 541–546.
15. Jornayvaz FR, Raguso CA, Philippe J (2007) Diabetes mellitus and driving. Rev
Med Suisse 3: 1437–1438, 1440–1441.
16. Gill G, Durston J, Johnston R, MacLeod K, Watkins P (2002) Insulin-treated
diabetes and driving in the UK. Diabet Med 19: 435–439.
17. American Diabetes Association (2004) Standards of medical care in diabetes.
Diabetes Care 27: S15–S35.
18. Canadian Medical Association (2006) Section 17: Endocrine and metabolic
disorders. Determining medical fitness to operate motor vehicles. CMA driver’s
guide, 7th edition. pp 74–81. Available: http://www.cma.ca/multimedia/CMA/
Content_Images/Inside_cma/WhatWePublish/Drivers_Guide/Section17_e.pdf.
Accessed 15 October 2009.
19. Redelmeier DA, Venkatesh V, Stanbrook MB (2008) Mandatory reporting by
physicians of patients potentially unfit to drive. Open Medicine 2: 8–17.
20. Ontario Ministry of Transportation Driver Improvement Office (2009) Medical
review section. Available: http://www.mto.gov.on.ca/english/dandv/driver/
medical-review/. Accessed 15 October 2009.
21. Carpinelli A, Mosca A, Bonini P (1986) Evaluation of a new semi-automated
high-performance liquid chromatography method for glycosylated haemoglo-
bins. J Automat Chem 8: 192–196.
22. Manley S, John WG, Marshall S (2004) Introduction of IFCC reference method
for calibration of HbA1c: implications for clinical care. Diabetic Med 21:
673–676.
23. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation
study of the number of events per variable in logistic regression analysis. J Clin
Epidemiol 49: 1373–1379.
24. Hulley SB, Cummings SR (1988) Designing clinical research. Baltimore:
Williams and Wilkins. 250 p.
25. Neuhauser M, Hothorn LA (1999) An exact Cochran-Armitage test for trend
when dose-response shapes are a priori unknown. Comput Stat Data Anal 30:
403–412.
26. Sackett DL (1979) Bias in analytic research. J Chron Dis 32: 52–63.
27. Fildes BN (2008) Future directions for older driver research. Traffic Inj Prev 9:
387–393.
28. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, et al. (2009) The
preventable causes of death in the United States: comparative risk assessment of
dietary, lifestyle, and metabolic risk factors. PLoS Med 6: e1000058.
doi:10.1371/journal.pmed.1000058.
29. Williams AF (2009) Licensing age and teenage driver crashes: a review of the
evidence. Traffic Inj Prev 10: 9–15.
30. Eberhard J (2008) Older drivers’ ‘‘high per mile crash involvement’’: the
implications for licensing authorities. Traffic Inj Prev 9: 284–290.
31. Action to Control Cardiovascular Risk in Diabetes Study Group (2008) Effects of
intensive glucose lowering in type 2 diabetes. N Engl J Med 358: 2545–2559.
32. ADVANCE Collaborative Group (2008) Intensive blood glucose control and
vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:
2560–2572.
33. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, et al. (2009) Glucose
control and vascular complications in veterans with type 2 diabetes. N Engl J Med
360: 129–139.
34. Weinger K, Kinsley BT, Levy CJ, Bajaj M, Simonson DC, et al. (1999) The
perception of safe driving ability during hypoglycemia in patients with type 1
diabetes mellitus. Am J Med 107: 246–253.
35. Clarke WL, Cox DJ, Gonder-Frederick LA, Kovatchev B (1999) Hypoglycemia
and the decision to drive a motor vehicle by persons with diabetes. JAMA 282:
750–754.
36. Cox DJ, Gonder-Frederick LA, Kovatchev BP, Julian DM, Clarke WL (2000)
Progressive hypoglycemia’s impact on driving simulation performance. Occur-
rence, awareness and correction. Diabetes Care 23: 163–170.
37. Stork AD, van Haeften TW, Veneman TF (2007) The decision not to drive
during hypoglycemia in patients with type 1 and type 2 diabetes according to
hypoglycemia awareness. Diabetes Care 30: 2822–2826.
38. Kennedy RL, Henry J, Chapman AJ, Nayar R, Grant P, et al. (2002) Accidents
in patients with insulin-treated diabetes: increased risk of low-impact falls but not
motor vehicle crashes–a prospective register-based study. J Trauma 52:
660–666.
39. Begg IS, Yale JF, Houlden RL, Rowe RC, McSherry J (2003) Canadian
Diabetes Association’s clinical practice guidelines for diabetes and private and
commercial driving. Can J Diabetes 27: 128–148.
Vehicle Crashes in Diabetic Patients
PLoS Medicine | www.plosmedicine.org 6 December 2009 | Volume 6 | Issue 12 | e1000192Editors’ Summary
Background. Around 8% of the US population has
diabetes, a group of diseases in which the body cannot
control levels of glucose (sugar) in the blood. It can lead to
serious complications and premature death, but suitable
treatment can control the disease and lower the risk of
complications.
Type 1 diabetes occurs when the body’s immune system
prevents the production of insulin, the hormone that
controls blood glucose. It accounts for 5%–10% of diabetes
cases in adults and the vast majority of cases in childhood.
Patients with type 1 diabetes need to inject insulin to
survive. Type 2 diabetes is associated with older age, obesity,
family history of diabetes, lack of physical activity, and race/
ethnicity. As obesity rates rise worldwide, it is expected that
the prevalence of type 2 diabetes will increase.
Why Was This Study Done? Some complications of
diabetes affect the ability to drive safely. Prolonged periods
of high blood sugar levels can damage eyesight and nerves
throughout the body, resulting in pain, tingling, and
reduction of feeling or muscle control. Over time, some
diabetics may become unaware of the early symptoms
of an abnormally low blood sugar level (hypoglycemia)
that can cause confusion, clumsiness, or fainting. Severe
hypoglycemia can result in seizures or a coma.
It is common for driver licensing authorities to require
evidence that a diabetic person’s condition is well controlled
before they issue a driving license. One measure of this is the
percentage of hemoglobin in their blood that has joined up
with glucose, known as HbA1c. This provides a measure of
average blood glucose levels over the previous 8–12 weeks.
A lower reading is considered an indicator of good diabetic
control, but conversely, a blood glucose level that is too low
can cause hypoglycemia. Normal nondiabetic HbA1c is
between 3.5% and 5.5%, but 6.5% is considered good for
people with diabetes.
In this study the researchers tested whether blood glucose
levels, as measured by levels of HbA1c, were statistically
associated with the risk of a motor vehicle crash.
What Did the Researchers Do and Find? The authors
studied 795 diabetic adults who had been in contact with
the driver licensing authority in Ontario, Canada between
January 1, 2005 and January 1, 2007 and for whom HbA1c
levels were recorded. HbA1c levels varied between 4.4% and
14.7%.
Of the drivers considered, 57 were involved in a car crash and
738 were not. The authors found that lower HbA1c levels
were associated with an increased risk of a motor vehicle
crash, even when they took into account other factors such
as time since diagnosis, treatment, age, age when diag-
nosed, and, if taking insulin, age insulin started.
The authors also found that the risk of a crash quadrupled
when a driver had a history of severe hypoglycemia that
required outside help and that there was an increase in risk
when diabetes had first been diagnosed at an older age.
What Do These Findings Mean? The authors conclude by
emphasizing the difficulty in knowing whether someone
with diabetes is fit to drive. They suggest that a patient’s
HbA1c level is neither necessary nor sufficient to determine
whether a diabetic person is fit to drive and these results,
which agree with some other studies, call into question the
current legal framework of the US, UK, Canada, Germany,
Holland, and Australia, which single out diabetic drivers for
medical review.
The finding that lower HbA1c levels are associated with an
increased risk of a crash is surprising, as it suggests that a
driver is less safe if they control their diabetes well. However,
a statistical link does not prove that one event causes
another. Unknown social or medical factors might explain
the results. In this case, the authors point out that a major
drawback of their study is that it is not randomized and
drivers have free will in choosing how tightly to control their
diabetes and also how carefully they drive. The authors
considered whether time spent driving might explain the
results, but discounted this for several reasons. One more
plausible explanation is that intensive treatment to attain a
lower HbA1c level for better general health raises the risk of
hypoglycemic episodes.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000192.
N Wikipedia includes an article on diabetes (note that
Wikipedia is a free online encyclopedia that anyone can
edit; available in several languages)
N The American Diabetes Association publishes information
on diabetes in English and Spanish
N The American Diabetes Association also publishes infor-
mation on US states’ regulation of drivers with diabetes
N The World Health Organization of the United Nations’
Diabetes Programme works to prevent diabetes, minimize
complications, and maximize quality of life
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